Translational and Clinical Correlates Core for ROBIN Program
Official title: Translational and Clinical Trial Correlates Core
Funded at Cleveland Clinic Lerner Com-Cwru · NIH-11416572 · Data updated 2026-11-12
A dedicated core provides advanced sample handling, high-tech profiling, and expert data analysis to support ROBIN Program studies and clinical trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project start | September 14, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $379,608 |
| NIH project number | 5U54CA274513-05 |
| Project ID | NIH-11416572 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients participating in ROBIN Program studies or related clinical trials that require high-quality biospecimens and molecular analyses.
✕Less likely to help
Patients not contributing biospecimens or not involved in studies using correlative molecular analyses.
What this research studies
If you participate in ROBIN Program studies, this core ensures samples are collected, stored, and annotated with high quality. It also gives researchers access to immune, genomic, proteomic, radiomic, and computational biology tools to understand how treatments affect patients at a molecular level. The core teams up with biobanking, immunology, and bioinformatics experts to deliver reliable data that can guide personalized care and improve trial interpretations. The aim is to harmonize data and provide robust analyses so results are meaningful for patient care.
Why it matters
Potential benefit: Better understanding of how treatments influence molecular markers could lead to more effective therapies and personalized treatment decisions.
How similar studies have gone: Similar correlative cores in other programs have produced actionable molecular insights and validated biomarkers.
Where this research is happening
-
Cleveland Clinic Lerner Com-Cwru
Cleveland, United States Active
Researchers
- Principal investigator: Diaz-Montero, Claudia Marcela — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Diaz-Montero, Claudia Marcela
Related research
Other NIH-funded projects on the same topics.
-
Susceptibility-based MRI biomarkers for multiple sclerosis
A short-term study aims to test MRI biomarkers that could help diagnose and predict MS in patients, using advanced imaging techniques.
-
Population genomics in peripartum cardiomyopathy
A gene-focused study to understand why some women develop heart failure around and after pregnancy, with an emphasis on African ancestry.
-
Broad antiviral therapy by targeting a key enzyme in nucleotide synthesis
A plan to block a human enzyme that many viruses need, with the aim of creating a broad-spectrum antiviral treatment for infections like SARS-CoV-2, influenza, and HSV-1.
-
Cellular-level Vascular Oculomics for Monitoring Systemic Vascular Health
A multi-site project using eye imaging and AI to monitor blood vessel health in people, with devices and software developed across four clinical sites.
-
Cellular-level Eye Signals to Track Vascular Health
A multi-site project aims to create and test portable imaging devices and AI tools that can monitor blood vessel health through the eye.
-
Outcomes in cirrhosis from different causes and the role of HIV and simvastatin
This study looks at how cirrhosis from alcohol, HIV, and other causes affects patients and whether simvastatin can influence outcomes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.